nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—Dactinomycin—muscle cancer	0.0216	0.303	CbGbCtD
Bepridil—ABCB1—Vincristine—muscle cancer	0.0133	0.187	CbGbCtD
Bepridil—ABCB1—Etoposide—muscle cancer	0.0122	0.171	CbGbCtD
Bepridil—PDE1A—smooth muscle tissue—muscle cancer	0.0094	0.0283	CbGeAlD
Bepridil—TNNC1—cardiac atrium—muscle cancer	0.00927	0.0279	CbGeAlD
Bepridil—PDE1A—renal system—muscle cancer	0.00905	0.0272	CbGeAlD
Bepridil—KCNQ1—renal system—muscle cancer	0.00841	0.0253	CbGeAlD
Bepridil—ABCB1—Doxorubicin—muscle cancer	0.00832	0.117	CbGbCtD
Bepridil—CACNA1A—head—muscle cancer	0.00828	0.0249	CbGeAlD
Bepridil—TNNC1—tendon—muscle cancer	0.00808	0.0243	CbGeAlD
Bepridil—ABCB1—Methotrexate—muscle cancer	0.00806	0.113	CbGbCtD
Bepridil—CACNA1A—testis—muscle cancer	0.008	0.0241	CbGeAlD
Bepridil—CYP2D6—Doxorubicin—muscle cancer	0.00784	0.11	CbGbCtD
Bepridil—CACNA2D2—cardiac atrium—muscle cancer	0.0078	0.0235	CbGeAlD
Bepridil—KCNQ1—cardiac atrium—muscle cancer	0.00754	0.0227	CbGeAlD
Bepridil—CACNA1H—smooth muscle tissue—muscle cancer	0.00734	0.0221	CbGeAlD
Bepridil—PDE1B—head—muscle cancer	0.00723	0.0217	CbGeAlD
Bepridil—PDE1A—tendon—muscle cancer	0.00707	0.0212	CbGeAlD
Bepridil—PDE1B—testis—muscle cancer	0.00698	0.021	CbGeAlD
Bepridil—TNNC1—testis—muscle cancer	0.00669	0.0201	CbGeAlD
Bepridil—KCNQ1—bone marrow—muscle cancer	0.00636	0.0191	CbGeAlD
Bepridil—CACNA2D2—vagina—muscle cancer	0.00631	0.019	CbGeAlD
Bepridil—PDE1A—head—muscle cancer	0.00606	0.0182	CbGeAlD
Bepridil—PDE1A—testis—muscle cancer	0.00585	0.0176	CbGeAlD
Bepridil—CACNA2D2—head—muscle cancer	0.00583	0.0175	CbGeAlD
Bepridil—CACNA2D2—testis—muscle cancer	0.00563	0.0169	CbGeAlD
Bepridil—KCNQ1—head—muscle cancer	0.00563	0.0169	CbGeAlD
Bepridil—CACNA1C—smooth muscle tissue—muscle cancer	0.00559	0.0168	CbGeAlD
Bepridil—KCNQ1—testis—muscle cancer	0.00544	0.0164	CbGeAlD
Bepridil—ATP1A1—embryo—muscle cancer	0.00531	0.016	CbGeAlD
Bepridil—CACNA1D—cardiac atrium—muscle cancer	0.00522	0.0157	CbGeAlD
Bepridil—CACNA1C—cardiac atrium—muscle cancer	0.00482	0.0145	CbGeAlD
Bepridil—CALM3—smooth muscle tissue—muscle cancer	0.00468	0.0141	CbGeAlD
Bepridil—CALM2—embryo—muscle cancer	0.00468	0.0141	CbGeAlD
Bepridil—CALM1—embryo—muscle cancer	0.00466	0.014	CbGeAlD
Bepridil—CACNA1H—testis—muscle cancer	0.00457	0.0137	CbGeAlD
Bepridil—ATP1A1—smooth muscle tissue—muscle cancer	0.00418	0.0126	CbGeAlD
Bepridil—CALM3—cardiac atrium—muscle cancer	0.00404	0.0121	CbGeAlD
Bepridil—ATP1A1—renal system—muscle cancer	0.00402	0.0121	CbGeAlD
Bepridil—CACNA1D—head—muscle cancer	0.0039	0.0117	CbGeAlD
Bepridil—CACNA1C—vagina—muscle cancer	0.0039	0.0117	CbGeAlD
Bepridil—CACNA1D—testis—muscle cancer	0.00377	0.0113	CbGeAlD
Bepridil—CALM2—smooth muscle tissue—muscle cancer	0.00368	0.0111	CbGeAlD
Bepridil—CALM1—smooth muscle tissue—muscle cancer	0.00366	0.011	CbGeAlD
Bepridil—CACNA1C—head—muscle cancer	0.0036	0.0108	CbGeAlD
Bepridil—ATP1A1—cardiac atrium—muscle cancer	0.0036	0.0108	CbGeAlD
Bepridil—CALM2—renal system—muscle cancer	0.00354	0.0106	CbGeAlD
Bepridil—CALM1—renal system—muscle cancer	0.00353	0.0106	CbGeAlD
Bepridil—CALM3—tendon—muscle cancer	0.00352	0.0106	CbGeAlD
Bepridil—CACNA1C—testis—muscle cancer	0.00348	0.0105	CbGeAlD
Bepridil—CALM3—bone marrow—muscle cancer	0.00341	0.0103	CbGeAlD
Bepridil—CALM3—vagina—muscle cancer	0.00327	0.00982	CbGeAlD
Bepridil—KCNH2—renal system—muscle cancer	0.00321	0.00965	CbGeAlD
Bepridil—CALM2—cardiac atrium—muscle cancer	0.00317	0.00954	CbGeAlD
Bepridil—CALM1—cardiac atrium—muscle cancer	0.00316	0.00949	CbGeAlD
Bepridil—ATP1A1—tendon—muscle cancer	0.00314	0.00944	CbGeAlD
Bepridil—ATP1A1—bone marrow—muscle cancer	0.00304	0.00914	CbGeAlD
Bepridil—CALM3—testis—muscle cancer	0.00291	0.00876	CbGeAlD
Bepridil—ATP1A1—vagina—muscle cancer	0.00291	0.00876	CbGeAlD
Bepridil—KCNH2—cardiac atrium—muscle cancer	0.00287	0.00864	CbGeAlD
Bepridil—CALM2—tendon—muscle cancer	0.00276	0.00831	CbGeAlD
Bepridil—CALM1—tendon—muscle cancer	0.00275	0.00827	CbGeAlD
Bepridil—ATP1A1—head—muscle cancer	0.00269	0.00809	CbGeAlD
Bepridil—CALM2—bone marrow—muscle cancer	0.00268	0.00805	CbGeAlD
Bepridil—CALM1—bone marrow—muscle cancer	0.00267	0.00801	CbGeAlD
Bepridil—ATP1A1—testis—muscle cancer	0.0026	0.00781	CbGeAlD
Bepridil—CALM2—vagina—muscle cancer	0.00257	0.00771	CbGeAlD
Bepridil—CALM1—vagina—muscle cancer	0.00255	0.00768	CbGeAlD
Bepridil—KCNH2—bone marrow—muscle cancer	0.00243	0.00729	CbGeAlD
Bepridil—CALM2—head—muscle cancer	0.00237	0.00712	CbGeAlD
Bepridil—CALM1—head—muscle cancer	0.00236	0.00709	CbGeAlD
Bepridil—KCNH2—vagina—muscle cancer	0.00232	0.00699	CbGeAlD
Bepridil—CALM2—testis—muscle cancer	0.00229	0.00688	CbGeAlD
Bepridil—CALM1—testis—muscle cancer	0.00228	0.00685	CbGeAlD
Bepridil—Loss of libido—Methotrexate—muscle cancer	0.00215	0.0259	CcSEcCtD
Bepridil—KCNH2—head—muscle cancer	0.00215	0.00645	CbGeAlD
Bepridil—Sinus tachycardia—Doxorubicin—muscle cancer	0.00213	0.0257	CcSEcCtD
Bepridil—KCNH2—testis—muscle cancer	0.00207	0.00623	CbGeAlD
Bepridil—CYP2D6—renal system—muscle cancer	0.00196	0.00588	CbGeAlD
Bepridil—Sudden death—Methotrexate—muscle cancer	0.00194	0.0233	CcSEcCtD
Bepridil—ABCB1—embryo—muscle cancer	0.00186	0.00559	CbGeAlD
Bepridil—Liver function test abnormal—Dactinomycin—muscle cancer	0.00153	0.0185	CcSEcCtD
Bepridil—ABCB1—renal system—muscle cancer	0.00141	0.00423	CbGeAlD
Bepridil—CYP2D6—head—muscle cancer	0.00131	0.00394	CbGeAlD
Bepridil—CYP2D6—testis—muscle cancer	0.00126	0.0038	CbGeAlD
Bepridil—Cardiac failure—Etoposide—muscle cancer	0.00123	0.0148	CcSEcCtD
Bepridil—Erectile dysfunction—Vincristine—muscle cancer	0.00118	0.0142	CcSEcCtD
Bepridil—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00116	0.014	CcSEcCtD
Bepridil—Pharyngitis—Dactinomycin—muscle cancer	0.00114	0.0137	CcSEcCtD
Bepridil—Depression—Vincristine—muscle cancer	0.00114	0.0137	CcSEcCtD
Bepridil—Sweating—Vincristine—muscle cancer	0.0011	0.0132	CcSEcCtD
Bepridil—ABCB1—bone marrow—muscle cancer	0.00106	0.0032	CbGeAlD
Bepridil—ABCB1—vagina—muscle cancer	0.00102	0.00306	CbGeAlD
Bepridil—Vasodilation procedure—Doxorubicin—muscle cancer	0.000977	0.0118	CcSEcCtD
Bepridil—Vasodilation—Doxorubicin—muscle cancer	0.000977	0.0118	CcSEcCtD
Bepridil—Cardiac disorder—Vincristine—muscle cancer	0.000953	0.0115	CcSEcCtD
Bepridil—ABCB1—head—muscle cancer	0.000942	0.00283	CbGeAlD
Bepridil—ABCB1—testis—muscle cancer	0.00091	0.00273	CbGeAlD
Bepridil—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000859	0.0103	CcSEcCtD
Bepridil—Myalgia—Dactinomycin—muscle cancer	0.000851	0.0102	CcSEcCtD
Bepridil—Oedema—Dactinomycin—muscle cancer	0.000816	0.00982	CcSEcCtD
Bepridil—Vertigo—Vincristine—muscle cancer	0.000803	0.00966	CcSEcCtD
Bepridil—Anorexia—Dactinomycin—muscle cancer	0.000778	0.00936	CcSEcCtD
Bepridil—Cardiac disorder—Etoposide—muscle cancer	0.000772	0.00929	CcSEcCtD
Bepridil—Hypertension—Vincristine—muscle cancer	0.000771	0.00928	CcSEcCtD
Bepridil—Myalgia—Vincristine—muscle cancer	0.000761	0.00916	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000744	0.00895	CcSEcCtD
Bepridil—Oedema—Vincristine—muscle cancer	0.000729	0.00878	CcSEcCtD
Bepridil—Decreased appetite—Dactinomycin—muscle cancer	0.000709	0.00854	CcSEcCtD
Bepridil—Hyperhidrosis—Vincristine—muscle cancer	0.000705	0.00848	CcSEcCtD
Bepridil—Pain—Dactinomycin—muscle cancer	0.000698	0.0084	CcSEcCtD
Bepridil—Anorexia—Vincristine—muscle cancer	0.000695	0.00837	CcSEcCtD
Bepridil—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000667	0.00803	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—muscle cancer	0.000665	0.008	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000664	0.008	CcSEcCtD
Bepridil—Increased appetite—Doxorubicin—muscle cancer	0.000663	0.00799	CcSEcCtD
Bepridil—Insomnia—Vincristine—muscle cancer	0.00066	0.00794	CcSEcCtD
Bepridil—Paraesthesia—Vincristine—muscle cancer	0.000655	0.00788	CcSEcCtD
Bepridil—Vertigo—Etoposide—muscle cancer	0.00065	0.00783	CcSEcCtD
Bepridil—Body temperature increased—Dactinomycin—muscle cancer	0.000645	0.00777	CcSEcCtD
Bepridil—Abdominal pain—Dactinomycin—muscle cancer	0.000645	0.00777	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—muscle cancer	0.000639	0.00769	CcSEcCtD
Bepridil—Loss of consciousness—Etoposide—muscle cancer	0.000636	0.00766	CcSEcCtD
Bepridil—Decreased appetite—Vincristine—muscle cancer	0.000634	0.00763	CcSEcCtD
Bepridil—Cough—Etoposide—muscle cancer	0.000632	0.0076	CcSEcCtD
Bepridil—Gastrointestinal disorder—Vincristine—muscle cancer	0.00063	0.00758	CcSEcCtD
Bepridil—Hypertension—Etoposide—muscle cancer	0.000625	0.00752	CcSEcCtD
Bepridil—Constipation—Vincristine—muscle cancer	0.000624	0.00751	CcSEcCtD
Bepridil—Pain—Vincristine—muscle cancer	0.000624	0.00751	CcSEcCtD
Bepridil—Abdominal discomfort—Methotrexate—muscle cancer	0.000596	0.00718	CcSEcCtD
Bepridil—Gastrointestinal pain—Vincristine—muscle cancer	0.000596	0.00718	CcSEcCtD
Bepridil—Asthenia—Dactinomycin—muscle cancer	0.000586	0.00705	CcSEcCtD
Bepridil—Body temperature increased—Vincristine—muscle cancer	0.000576	0.00694	CcSEcCtD
Bepridil—Abdominal pain—Vincristine—muscle cancer	0.000576	0.00694	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—muscle cancer	0.000576	0.00693	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—muscle cancer	0.000573	0.0069	CcSEcCtD
Bepridil—Hyperhidrosis—Etoposide—muscle cancer	0.000571	0.00687	CcSEcCtD
Bepridil—Anorexia—Etoposide—muscle cancer	0.000563	0.00678	CcSEcCtD
Bepridil—Diarrhoea—Dactinomycin—muscle cancer	0.000558	0.00672	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—muscle cancer	0.000555	0.00668	CcSEcCtD
Bepridil—Depression—Methotrexate—muscle cancer	0.000553	0.00666	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—muscle cancer	0.000552	0.00664	CcSEcCtD
Bepridil—Influenza—Doxorubicin—muscle cancer	0.000539	0.00648	CcSEcCtD
Bepridil—Sweating—Methotrexate—muscle cancer	0.000532	0.0064	CcSEcCtD
Bepridil—Paraesthesia—Etoposide—muscle cancer	0.00053	0.00638	CcSEcCtD
Bepridil—Dyspnoea—Etoposide—muscle cancer	0.000527	0.00634	CcSEcCtD
Bepridil—Somnolence—Etoposide—muscle cancer	0.000525	0.00632	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—muscle cancer	0.000525	0.00632	CcSEcCtD
Bepridil—Asthenia—Vincristine—muscle cancer	0.000523	0.0063	CcSEcCtD
Bepridil—Rash—Dactinomycin—muscle cancer	0.000515	0.00619	CcSEcCtD
Bepridil—Decreased appetite—Etoposide—muscle cancer	0.000514	0.00618	CcSEcCtD
Bepridil—Gastrointestinal disorder—Etoposide—muscle cancer	0.00051	0.00614	CcSEcCtD
Bepridil—Constipation—Etoposide—muscle cancer	0.000505	0.00608	CcSEcCtD
Bepridil—Pain—Etoposide—muscle cancer	0.000505	0.00608	CcSEcCtD
Bepridil—Diarrhoea—Vincristine—muscle cancer	0.000499	0.006	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—muscle cancer	0.000494	0.00595	CcSEcCtD
Bepridil—Nausea—Dactinomycin—muscle cancer	0.000485	0.00583	CcSEcCtD
Bepridil—Gastrointestinal pain—Etoposide—muscle cancer	0.000483	0.00581	CcSEcCtD
Bepridil—Dizziness—Vincristine—muscle cancer	0.000482	0.0058	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—muscle cancer	0.00048	0.00578	CcSEcCtD
Bepridil—Abdominal pain—Etoposide—muscle cancer	0.000467	0.00562	CcSEcCtD
Bepridil—Body temperature increased—Etoposide—muscle cancer	0.000467	0.00562	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—muscle cancer	0.000464	0.00559	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—muscle cancer	0.000462	0.00556	CcSEcCtD
Bepridil—Sweating—Doxorubicin—muscle cancer	0.000461	0.00554	CcSEcCtD
Bepridil—Rash—Vincristine—muscle cancer	0.00046	0.00553	CcSEcCtD
Bepridil—Dermatitis—Vincristine—muscle cancer	0.000459	0.00553	CcSEcCtD
Bepridil—Headache—Vincristine—muscle cancer	0.000457	0.0055	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—muscle cancer	0.000439	0.00528	CcSEcCtD
Bepridil—Nausea—Vincristine—muscle cancer	0.000433	0.00521	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—muscle cancer	0.000432	0.0052	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—muscle cancer	0.000428	0.00515	CcSEcCtD
Bepridil—Asthenia—Etoposide—muscle cancer	0.000424	0.0051	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—muscle cancer	0.000409	0.00492	CcSEcCtD
Bepridil—Diarrhoea—Etoposide—muscle cancer	0.000404	0.00486	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—muscle cancer	0.000402	0.00484	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—muscle cancer	0.0004	0.00482	CcSEcCtD
Bepridil—Dizziness—Etoposide—muscle cancer	0.000391	0.0047	CcSEcCtD
Bepridil—Vertigo—Methotrexate—muscle cancer	0.00039	0.00469	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—muscle cancer	0.000385	0.00464	CcSEcCtD
Bepridil—Cough—Methotrexate—muscle cancer	0.000378	0.00455	CcSEcCtD
Bepridil—Rash—Etoposide—muscle cancer	0.000372	0.00448	CcSEcCtD
Bepridil—Dermatitis—Etoposide—muscle cancer	0.000372	0.00448	CcSEcCtD
Bepridil—Headache—Etoposide—muscle cancer	0.00037	0.00445	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—muscle cancer	0.00037	0.00445	CcSEcCtD
Bepridil—Myalgia—Methotrexate—muscle cancer	0.000369	0.00444	CcSEcCtD
Bepridil—Tension—Doxorubicin—muscle cancer	0.000368	0.00443	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—muscle cancer	0.000365	0.00439	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—muscle cancer	0.000354	0.00426	CcSEcCtD
Bepridil—Nausea—Etoposide—muscle cancer	0.000351	0.00422	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—muscle cancer	0.000342	0.00412	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—muscle cancer	0.000337	0.00406	CcSEcCtD
Bepridil—Anorexia—Methotrexate—muscle cancer	0.000337	0.00406	CcSEcCtD
Bepridil—Syncope—Doxorubicin—muscle cancer	0.000337	0.00405	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—muscle cancer	0.000332	0.00399	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—muscle cancer	0.00033	0.00397	CcSEcCtD
Bepridil—Cough—Doxorubicin—muscle cancer	0.000328	0.00394	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—muscle cancer	0.000324	0.0039	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000322	0.00388	CcSEcCtD
Bepridil—Insomnia—Methotrexate—muscle cancer	0.00032	0.00385	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—muscle cancer	0.00032	0.00385	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—muscle cancer	0.000318	0.00383	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—muscle cancer	0.000318	0.00382	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—muscle cancer	0.000315	0.0038	CcSEcCtD
Bepridil—Somnolence—Methotrexate—muscle cancer	0.000315	0.00379	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—muscle cancer	0.000313	0.00376	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—muscle cancer	0.000311	0.00375	CcSEcCtD
Bepridil—CALM3—B Cell Activation—KIT—muscle cancer	0.00031	0.000605	CbGpPWpGaD
Bepridil—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.000308	0.0006	CbGpPWpGaD
Bepridil—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.000308	0.0006	CbGpPWpGaD
Bepridil—Decreased appetite—Methotrexate—muscle cancer	0.000308	0.0037	CcSEcCtD
Bepridil—Oedema—Doxorubicin—muscle cancer	0.000306	0.00369	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000305	0.00368	CcSEcCtD
Bepridil—CALM3—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000303	0.00059	CbGpPWpGaD
Bepridil—Pain—Methotrexate—muscle cancer	0.000303	0.00364	CcSEcCtD
Bepridil—Shock—Doxorubicin—muscle cancer	0.000301	0.00363	CcSEcCtD
Bepridil—CALM2—B Cell Activation—KIT—muscle cancer	0.0003	0.000585	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—KIT—muscle cancer	0.0003	0.000585	CbGpPWpGaD
Bepridil—CALM3—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.0003	0.000584	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—FOXO1—muscle cancer	0.0003	0.000584	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000297	0.000579	CbGpPWpGaD
Bepridil—Hyperhidrosis—Doxorubicin—muscle cancer	0.000296	0.00356	CcSEcCtD
Bepridil—CALM2—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000293	0.000571	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000293	0.000571	CbGpPWpGaD
Bepridil—Anorexia—Doxorubicin—muscle cancer	0.000292	0.00351	CcSEcCtD
Bepridil—CACNA1C—Metabolism—ENO2—muscle cancer	0.00029	0.000565	CbGpPWpGaD
Bepridil—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.00029	0.000565	CbGpPWpGaD
Bepridil—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.00029	0.000565	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—FOXO1—muscle cancer	0.00029	0.000565	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—FOXO1—muscle cancer	0.00029	0.000565	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—VEGFA—muscle cancer	0.00029	0.000565	CbGpPWpGaD
Bepridil—Gastrointestinal pain—Methotrexate—muscle cancer	0.000289	0.00348	CcSEcCtD
Bepridil—CALM3—Alzheimers Disease—TP53—muscle cancer	0.000289	0.000563	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000287	0.00056	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000287	0.00056	CbGpPWpGaD
Bepridil—CALM3—Downstream signal transduction—MDM2—muscle cancer	0.000285	0.000555	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR—MDM2—muscle cancer	0.000283	0.000552	CbGpPWpGaD
Bepridil—CALM3—Signaling by VEGF—VEGFA—muscle cancer	0.000283	0.000552	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—MDM2—muscle cancer	0.000283	0.000551	CbGpPWpGaD
Bepridil—CALM3—Signaling by ERBB2—MDM2—muscle cancer	0.000282	0.00055	CbGpPWpGaD
Bepridil—CALM3—DAP12 signaling—MDM2—muscle cancer	0.00028	0.000547	CbGpPWpGaD
Bepridil—CACNA1C—Axon guidance—VEGFA—muscle cancer	0.00028	0.000546	CbGpPWpGaD
Bepridil—Body temperature increased—Methotrexate—muscle cancer	0.00028	0.00337	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—muscle cancer	0.00028	0.00337	CcSEcCtD
Bepridil—PDE1A—Signaling Pathways—PTCH1—muscle cancer	0.000279	0.000545	CbGpPWpGaD
Bepridil—CALM1—Alzheimers Disease—TP53—muscle cancer	0.000279	0.000544	CbGpPWpGaD
Bepridil—CALM2—Alzheimers Disease—TP53—muscle cancer	0.000279	0.000544	CbGpPWpGaD
Bepridil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000279	0.00336	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—muscle cancer	0.000277	0.00334	CcSEcCtD
Bepridil—CALM2—Downstream signal transduction—MDM2—muscle cancer	0.000275	0.000537	CbGpPWpGaD
Bepridil—CALM1—Downstream signal transduction—MDM2—muscle cancer	0.000275	0.000537	CbGpPWpGaD
Bepridil—Paraesthesia—Doxorubicin—muscle cancer	0.000275	0.00331	CcSEcCtD
Bepridil—PDE1A—Immune System—FOXO1—muscle cancer	0.000274	0.000535	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—MDM2—muscle cancer	0.000274	0.000534	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR—MDM2—muscle cancer	0.000274	0.000534	CbGpPWpGaD
Bepridil—CALM1—Signaling by VEGF—VEGFA—muscle cancer	0.000274	0.000534	CbGpPWpGaD
Bepridil—CALM2—Signaling by VEGF—VEGFA—muscle cancer	0.000274	0.000534	CbGpPWpGaD
Bepridil—Dyspnoea—Doxorubicin—muscle cancer	0.000273	0.00329	CcSEcCtD
Bepridil—CALM1—Signaling by ERBB2—MDM2—muscle cancer	0.000273	0.000532	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—MDM2—muscle cancer	0.000273	0.000532	CbGpPWpGaD
Bepridil—Somnolence—Doxorubicin—muscle cancer	0.000272	0.00328	CcSEcCtD
Bepridil—CALM2—DAP12 signaling—MDM2—muscle cancer	0.000271	0.000529	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—MDM2—muscle cancer	0.000271	0.000529	CbGpPWpGaD
Bepridil—Dyspepsia—Doxorubicin—muscle cancer	0.00027	0.00325	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—muscle cancer	0.000266	0.00321	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000265	0.00318	CcSEcCtD
Bepridil—CALM3—DAP12 interactions—MDM2—muscle cancer	0.000264	0.000514	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000264	0.000514	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—MDM2—muscle cancer	0.000264	0.000514	CbGpPWpGaD
Bepridil—Constipation—Doxorubicin—muscle cancer	0.000262	0.00315	CcSEcCtD
Bepridil—Pain—Doxorubicin—muscle cancer	0.000262	0.00315	CcSEcCtD
Bepridil—CALM3—Signaling by EGFR—MDM2—muscle cancer	0.000262	0.00051	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000259	0.000505	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—MDM2—muscle cancer	0.000259	0.000504	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—MDM2—muscle cancer	0.000258	0.000503	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KIDINS220—muscle cancer	0.000257	0.000502	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PTCH1—muscle cancer	0.000256	0.000498	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—MDM2—muscle cancer	0.000255	0.000498	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000255	0.000498	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—MDM2—muscle cancer	0.000255	0.000498	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000255	0.000498	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—MDM2—muscle cancer	0.000255	0.000498	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—MDM2—muscle cancer	0.000255	0.000498	CbGpPWpGaD
Bepridil—Asthenia—Methotrexate—muscle cancer	0.000254	0.00306	CcSEcCtD
Bepridil—PDE1A—Disease—FOXO1—muscle cancer	0.000253	0.000494	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—MDM2—muscle cancer	0.000253	0.000493	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—MDM2—muscle cancer	0.000253	0.000493	CbGpPWpGaD
Bepridil—PDE1B—Immune System—FOXO1—muscle cancer	0.000251	0.000489	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000251	0.000489	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000251	0.000489	CbGpPWpGaD
Bepridil—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000251	0.00302	CcSEcCtD
Bepridil—CALM2—Signaling by PDGF—MDM2—muscle cancer	0.00025	0.000487	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—MDM2—muscle cancer	0.00025	0.000487	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIDINS220—muscle cancer	0.000249	0.000485	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIDINS220—muscle cancer	0.000249	0.000485	CbGpPWpGaD
Bepridil—CALM3—Metabolism—FH—muscle cancer	0.000248	0.000484	CbGpPWpGaD
Bepridil—CALM3—B Cell Activation—MDM2—muscle cancer	0.000244	0.000476	CbGpPWpGaD
Bepridil—Abdominal pain—Doxorubicin—muscle cancer	0.000242	0.00291	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—muscle cancer	0.000242	0.00291	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—muscle cancer	0.000242	0.00291	CcSEcCtD
Bepridil—PDE1A—Signaling Pathways—FOXO4—muscle cancer	0.00024	0.000468	CbGpPWpGaD
Bepridil—CALM2—Metabolism—FH—muscle cancer	0.00024	0.000468	CbGpPWpGaD
Bepridil—CALM1—Metabolism—FH—muscle cancer	0.00024	0.000468	CbGpPWpGaD
Bepridil—CALM3—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000239	0.000467	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—VEGFA—muscle cancer	0.000238	0.000465	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—MDM2—muscle cancer	0.000236	0.000461	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—MDM2—muscle cancer	0.000236	0.000461	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CNR1—muscle cancer	0.000236	0.00046	CbGpPWpGaD
Bepridil—Dizziness—Methotrexate—muscle cancer	0.000234	0.00282	CcSEcCtD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000234	0.000456	CbGpPWpGaD
Bepridil—PDE1B—Disease—FOXO1—muscle cancer	0.000232	0.000452	CbGpPWpGaD
Bepridil—CALM2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000231	0.000451	CbGpPWpGaD
Bepridil—CALM1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000231	0.000451	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—FOXO4—muscle cancer	0.000231	0.000451	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—KIT—muscle cancer	0.000228	0.000445	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—VEGFA—muscle cancer	0.000228	0.000444	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000226	0.000441	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000226	0.000441	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—FOXO4—muscle cancer	0.000224	0.000436	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—FOXO4—muscle cancer	0.000224	0.000436	CbGpPWpGaD
Bepridil—Rash—Methotrexate—muscle cancer	0.000223	0.00269	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—muscle cancer	0.000223	0.00268	CcSEcCtD
Bepridil—CALM3—Adaptive Immune System—FOXO4—muscle cancer	0.000222	0.000433	CbGpPWpGaD
Bepridil—Headache—Methotrexate—muscle cancer	0.000222	0.00267	CcSEcCtD
Bepridil—CALM2—Signaling by NGF—KIT—muscle cancer	0.000221	0.00043	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—KIT—muscle cancer	0.000221	0.00043	CbGpPWpGaD
Bepridil—Asthenia—Doxorubicin—muscle cancer	0.00022	0.00265	CcSEcCtD
Bepridil—PDE1B—Signaling Pathways—FOXO4—muscle cancer	0.00022	0.000428	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—VEGFA—muscle cancer	0.000218	0.000425	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CNR1—muscle cancer	0.000216	0.00042	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—FOXO4—muscle cancer	0.000215	0.000419	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—FOXO4—muscle cancer	0.000215	0.000419	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—PTGS2—muscle cancer	0.000211	0.000412	CbGpPWpGaD
Bepridil—Nausea—Methotrexate—muscle cancer	0.00021	0.00253	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—muscle cancer	0.00021	0.00252	CcSEcCtD
Bepridil—PDE1A—Immune System—KIT—muscle cancer	0.000209	0.000408	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—IGF2—muscle cancer	0.000206	0.000402	CbGpPWpGaD
Bepridil—Dizziness—Doxorubicin—muscle cancer	0.000203	0.00244	CcSEcCtD
Bepridil—CACNA1C—Developmental Biology—VEGFA—muscle cancer	0.0002	0.00039	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—IGF2—muscle cancer	0.000199	0.000389	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—IGF2—muscle cancer	0.000199	0.000389	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD34—muscle cancer	0.000198	0.000386	CbGpPWpGaD
Bepridil—Rash—Doxorubicin—muscle cancer	0.000193	0.00232	CcSEcCtD
Bepridil—PDE1A—Disease—KIT—muscle cancer	0.000193	0.000376	CbGpPWpGaD
Bepridil—Dermatitis—Doxorubicin—muscle cancer	0.000193	0.00232	CcSEcCtD
Bepridil—PDE1A—Signaling Pathways—IGF2—muscle cancer	0.000193	0.000376	CbGpPWpGaD
Bepridil—Headache—Doxorubicin—muscle cancer	0.000192	0.00231	CcSEcCtD
Bepridil—CALM2—Immune System—CD34—muscle cancer	0.000192	0.000374	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD34—muscle cancer	0.000192	0.000374	CbGpPWpGaD
Bepridil—PDE1B—Immune System—KIT—muscle cancer	0.000191	0.000373	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000188	0.000367	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—FH—muscle cancer	0.000188	0.000367	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—MDM2—muscle cancer	0.000183	0.000357	CbGpPWpGaD
Bepridil—Nausea—Doxorubicin—muscle cancer	0.000182	0.00219	CcSEcCtD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000181	0.000354	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—TP53—muscle cancer	0.00018	0.000351	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—MDM2—muscle cancer	0.00018	0.00035	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—FOXO1—muscle cancer	0.000177	0.000346	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—MDM2—muscle cancer	0.000177	0.000346	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—MDM2—muscle cancer	0.000177	0.000346	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—FH—muscle cancer	0.000177	0.000345	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—PTGS2—muscle cancer	0.000177	0.000345	CbGpPWpGaD
Bepridil—PDE1B—Disease—KIT—muscle cancer	0.000177	0.000344	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IGF2—muscle cancer	0.000176	0.000344	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—MDM2—muscle cancer	0.000174	0.000339	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—MDM2—muscle cancer	0.000174	0.000339	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PTCH1—muscle cancer	0.000171	0.000334	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—FOXO1—muscle cancer	0.000171	0.000333	CbGpPWpGaD
Bepridil—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000168	0.000327	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PTCH1—muscle cancer	0.000166	0.000323	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PTCH1—muscle cancer	0.000166	0.000323	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—FOXO1—muscle cancer	0.000165	0.000322	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—FOXO1—muscle cancer	0.000165	0.000322	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—TP53—muscle cancer	0.000165	0.000321	CbGpPWpGaD
Bepridil—PDE1A—Immune System—MDM2—muscle cancer	0.000165	0.000321	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—FOXO1—muscle cancer	0.000164	0.00032	CbGpPWpGaD
Bepridil—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000162	0.000316	CbGpPWpGaD
Bepridil—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000162	0.000316	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—FOXO1—muscle cancer	0.000162	0.000316	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—FOXO1—muscle cancer	0.000159	0.000309	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—FOXO1—muscle cancer	0.000159	0.000309	CbGpPWpGaD
Bepridil—CALM3—Disease—ENO2—muscle cancer	0.000153	0.000298	CbGpPWpGaD
Bepridil—PDE1A—Disease—MDM2—muscle cancer	0.000152	0.000296	CbGpPWpGaD
Bepridil—PDE1B—Immune System—MDM2—muscle cancer	0.000151	0.000294	CbGpPWpGaD
Bepridil—CALM2—Disease—ENO2—muscle cancer	0.000148	0.000288	CbGpPWpGaD
Bepridil—CALM1—Disease—ENO2—muscle cancer	0.000148	0.000288	CbGpPWpGaD
Bepridil—PDE1A—Disease—PTGS2—muscle cancer	0.000147	0.000286	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CNR1—muscle cancer	0.000145	0.000282	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000143	0.000279	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MED12—muscle cancer	0.00014	0.000273	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CNR1—muscle cancer	0.00014	0.000273	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CNR1—muscle cancer	0.00014	0.000273	CbGpPWpGaD
Bepridil—PDE1B—Disease—MDM2—muscle cancer	0.000139	0.000271	CbGpPWpGaD
Bepridil—CALM3—Disease—HMGA1—muscle cancer	0.000139	0.00027	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MED12—muscle cancer	0.000136	0.000264	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MED12—muscle cancer	0.000136	0.000264	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KIT—muscle cancer	0.000135	0.000264	CbGpPWpGaD
Bepridil—CALM3—Immune System—FOXO4—muscle cancer	0.000135	0.000263	CbGpPWpGaD
Bepridil—CALM2—Disease—HMGA1—muscle cancer	0.000134	0.000262	CbGpPWpGaD
Bepridil—CALM1—Disease—HMGA1—muscle cancer	0.000134	0.000262	CbGpPWpGaD
Bepridil—PDE1B—Disease—PTGS2—muscle cancer	0.000134	0.000261	CbGpPWpGaD
Bepridil—CALM1—Immune System—FOXO4—muscle cancer	0.00013	0.000254	CbGpPWpGaD
Bepridil—CALM2—Immune System—FOXO4—muscle cancer	0.00013	0.000254	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KIT—muscle cancer	0.00013	0.000254	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ENO2—muscle cancer	0.000128	0.000249	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KIT—muscle cancer	0.000126	0.000246	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KIT—muscle cancer	0.000126	0.000246	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KIT—muscle cancer	0.000125	0.000244	CbGpPWpGaD
Bepridil—CALM3—Disease—FOXO4—muscle cancer	0.000124	0.000243	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KIT—muscle cancer	0.000124	0.000241	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ENO2—muscle cancer	0.000124	0.000241	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ENO2—muscle cancer	0.000124	0.000241	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KIT—muscle cancer	0.000121	0.000236	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KIT—muscle cancer	0.000121	0.000236	CbGpPWpGaD
Bepridil—CALM1—Disease—FOXO4—muscle cancer	0.00012	0.000235	CbGpPWpGaD
Bepridil—CALM2—Disease—FOXO4—muscle cancer	0.00012	0.000235	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—PTGS2—muscle cancer	0.000115	0.000224	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000108	0.00021	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MDM2—muscle cancer	0.000106	0.000208	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MED12—muscle cancer	0.000106	0.000207	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—MDM2—muscle cancer	0.000103	0.0002	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTCH1—muscle cancer	0.000101	0.000198	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PTGS2—muscle cancer	0.000101	0.000197	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MED12—muscle cancer	0.0001	0.000195	CbGpPWpGaD
Bepridil—CALM3—Immune System—FOXO1—muscle cancer	9.95e-05	0.000194	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—MDM2—muscle cancer	9.92e-05	0.000193	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—MDM2—muscle cancer	9.92e-05	0.000193	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—MDM2—muscle cancer	9.85e-05	0.000192	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTCH1—muscle cancer	9.8e-05	0.000191	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTCH1—muscle cancer	9.8e-05	0.000191	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MDM2—muscle cancer	9.74e-05	0.00019	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ENO2—muscle cancer	9.69e-05	0.000189	CbGpPWpGaD
Bepridil—CALM2—Immune System—FOXO1—muscle cancer	9.63e-05	0.000188	CbGpPWpGaD
Bepridil—CALM1—Immune System—FOXO1—muscle cancer	9.63e-05	0.000188	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—MDM2—muscle cancer	9.52e-05	0.000186	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—MDM2—muscle cancer	9.52e-05	0.000186	CbGpPWpGaD
Bepridil—CALM3—Disease—FOXO1—muscle cancer	9.19e-05	0.000179	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ENO2—muscle cancer	9.13e-05	0.000178	CbGpPWpGaD
Bepridil—CALM2—Disease—FOXO1—muscle cancer	8.89e-05	0.000173	CbGpPWpGaD
Bepridil—CALM1—Disease—FOXO1—muscle cancer	8.89e-05	0.000173	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FOXO4—muscle cancer	8.71e-05	0.00017	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—VEGFA—muscle cancer	8.65e-05	0.000169	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CNR1—muscle cancer	8.55e-05	0.000167	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FOXO4—muscle cancer	8.43e-05	0.000164	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FOXO4—muscle cancer	8.43e-05	0.000164	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—VEGFA—muscle cancer	8.37e-05	0.000163	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—VEGFA—muscle cancer	8.37e-05	0.000163	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CNR1—muscle cancer	8.27e-05	0.000161	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CNR1—muscle cancer	8.27e-05	0.000161	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—VEGFA—muscle cancer	8.09e-05	0.000158	CbGpPWpGaD
Bepridil—CALM3—Immune System—KIT—muscle cancer	7.58e-05	0.000148	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—VEGFA—muscle cancer	7.39e-05	0.000144	CbGpPWpGaD
Bepridil—CALM2—Immune System—KIT—muscle cancer	7.33e-05	0.000143	CbGpPWpGaD
Bepridil—CALM1—Immune System—KIT—muscle cancer	7.33e-05	0.000143	CbGpPWpGaD
Bepridil—CALM3—Disease—KIT—muscle cancer	7e-05	0.000136	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF2—muscle cancer	6.99e-05	0.000136	CbGpPWpGaD
Bepridil—CALM2—Disease—KIT—muscle cancer	6.77e-05	0.000132	CbGpPWpGaD
Bepridil—CALM1—Disease—KIT—muscle cancer	6.77e-05	0.000132	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF2—muscle cancer	6.76e-05	0.000132	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF2—muscle cancer	6.76e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—muscle cancer	6.53e-05	0.000127	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FOXO1—muscle cancer	6.43e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—muscle cancer	6.32e-05	0.000123	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—muscle cancer	6.32e-05	0.000123	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FOXO1—muscle cancer	6.22e-05	0.000121	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FOXO1—muscle cancer	6.22e-05	0.000121	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—muscle cancer	6.11e-05	0.000119	CbGpPWpGaD
Bepridil—CALM3—Immune System—MDM2—muscle cancer	5.97e-05	0.000116	CbGpPWpGaD
Bepridil—CALM2—Immune System—MDM2—muscle cancer	5.78e-05	0.000113	CbGpPWpGaD
Bepridil—CALM1—Immune System—MDM2—muscle cancer	5.78e-05	0.000113	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—muscle cancer	5.59e-05	0.000109	CbGpPWpGaD
Bepridil—CALM3—Disease—MDM2—muscle cancer	5.51e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Disease—MDM2—muscle cancer	5.33e-05	0.000104	CbGpPWpGaD
Bepridil—CALM1—Disease—MDM2—muscle cancer	5.33e-05	0.000104	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—muscle cancer	5.32e-05	0.000104	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—muscle cancer	5.14e-05	0.0001	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—muscle cancer	5.14e-05	0.0001	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KIT—muscle cancer	4.9e-05	9.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIT—muscle cancer	4.74e-05	9.25e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIT—muscle cancer	4.74e-05	9.25e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—muscle cancer	4.45e-05	8.68e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—muscle cancer	4.31e-05	8.39e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—muscle cancer	4.31e-05	8.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MDM2—muscle cancer	3.86e-05	7.53e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MDM2—muscle cancer	3.73e-05	7.28e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MDM2—muscle cancer	3.73e-05	7.28e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—muscle cancer	3.37e-05	6.58e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—muscle cancer	3.18e-05	6.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—muscle cancer	2.93e-05	5.72e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—muscle cancer	2.84e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—muscle cancer	2.84e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—muscle cancer	2.22e-05	4.32e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—muscle cancer	2.14e-05	4.18e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—muscle cancer	2.14e-05	4.18e-05	CbGpPWpGaD
